CVRx, Inc. (CVRX)
CVRX moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How CVRX actually reacts to news — the realized, point-in-time move the market made, measured across 408 labeled events over the last three years with zero look-ahead.
CVRX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.08% | 37% | 400 |
| 30-min | 0.00% | 50% | 407 |
| 60-min | -0.12% | 47% | 407 |
| to close | 0.00% | 48% | 405 |
| Middle 50% of CVRX reactions | -1.64% to +1.09% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 408 |
Half of all CVRx, Inc. news events land between -1.64% and +1.09% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How CVRX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 15 | -5.86% | 33% | -5.40% |
| Rating reiterations | 39 | -0.89% | 36% | -0.21% |
| Price-target raises | 14 | -0.08% | 36% | +0.04% |
| Price-target cuts | 10 | -1.83% | 20% | -0.29% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how CVRX ranks against every other measured name →
That’s how CVRX usually reacts — get an email when it moves on news →Email me when CVRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CVRX's baseline. Nothing else.
Recent CVRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026 | Press release | GlobeNewswire | -1.14% | -33.46% | |
| CVRx Appoints John Landry as Chief Financial Officer | Press release | GlobeNewswire | +0.85% | -2.03% | |
| Form 8-K CVRx, Inc. For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | +0.85% | -2.03% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages CVRx, Inc. (CVRX) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | -2.64% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.16% | -4.10% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.76% | -0.15% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.61% | +2.90% | |
| CVRx Responds to Letter from Pointillist Family Office | Press release | GlobeNewswire | -0.63% | +6.31% | |
| CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy | Press release | GlobeNewswire | +8.70% | +5.35% | |
| Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer | Press release | PR Newswire | +8.70% | +5.35% | |
| CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +8.70% | +5.35% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages CVRx, Inc. (CVRX) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +1.04% | -1.22% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.18% | -1.26% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.00% | -9.54% | |
| CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.48% | -2.22% | |
| CVRx Announces Sales Leadership Transition | Press release | GlobeNewswire | +2.17% | +12.55% | |
| Form 8-K CVRx, Inc. For: Aug 10 | SEC filing · Form 8-K | SEC EDGAR | +2.17% | +12.55% | |
| CVRx Reports Second Quarter 2026 Financial and Operating Results | Press release | GlobeNewswire | -6.97% | -20.60% | |
| Form 10-Q CVRx, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -6.97% | -20.60% | |
| Form 8-K CVRx, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -6.97% | -20.60% | |
| CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference | Press release | GlobeNewswire | +3.83% | -0.20% | |
| CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026 | Press release | GlobeNewswire | +0.81% | -4.24% | |
| CVRx Announces Chief Financial Officer Transition | Press release | GlobeNewswire | +2.86% | -0.95% | |
| Form 8-K CVRx, Inc. For: Jun 07 | SEC filing · Form 8-K | SEC EDGAR | +2.86% | -0.95% | |
| Form 8-K CVRx, Inc. For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | -1.61% | +8.29% | |
| Form SD CVRx, Inc. | SEC filing · Form SD | SEC EDGAR | +0.00% | -0.71% | |
| CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference | Press release | GlobeNewswire | -0.21% | -2.43% | |
| CVRx to Present at the William Blair 46th Annual Growth Stock Conference | Press release | GlobeNewswire | -0.50% | +0.50% | |
| CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy | Press release | GlobeNewswire | +3.71% | +9.33% | |
| Form 10-Q CVRx, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -4.60% | -20.99% | |
| CVRx Reports First Quarter 2026 Financial and Operating Results | Press release | GlobeNewswire | -4.60% | -20.99% | |
| Form 8-K CVRx, Inc. For: May 11 | SEC filing · Form 8-K | SEC EDGAR | -4.60% | -20.99% | |
| CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population | Press release | GlobeNewswire | +0.13% | -5.18% | |
| CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026 | Press release | GlobeNewswire | +0.66% | -1.58% | |
| CVRx Announces Nomination of Michael Dale for Election to the Board of Directors | Press release | GlobeNewswire | -1.24% | +4.25% | |
| Form DEF 14A CVRx, Inc. For: Jun 01 | SEC filing · Form DEF | SEC EDGAR | -1.24% | +4.25% | |
| Form DEFA14A CVRx, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -1.24% | +4.25% | |
| CVRx Reports Preliminary First Quarter 2026 Financial Results | Press release | GlobeNewswire | -0.34% | +7.72% | |
| Form 8-K CVRx, Inc. For: Apr 13 | SEC filing · Form 8-K | SEC EDGAR | -0.34% | +7.72% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | -2.30% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -0.36% | -3.53% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | +4.69% | |
| CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | -3.11% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages CVRx, Inc. (CVRX) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.64% | +0.76% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.00% | +1.58% | |
| CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | +0.64% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.39% | +2.34% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages CVRx, Inc. (CVRX) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.80% | +0.80% | |
| Form 8-K CVRx, Inc. For: Feb 27 | SEC filing · Form 8-K | SEC EDGAR | +0.18% | +3.79% | |
| CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting | Press release | GlobeNewswire | +1.52% | +4.05% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CVRX section they belong to.
Where else CVRX is measured.
CVRX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is CVRx, Inc.'s median reaction calculated?
Every labeled CVRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 408 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of CVRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CVRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.